Nitric oxide and acute renal failure

Nephron

Volumn 73, Issue 3, 1996, Pages 375-381

  Peer, Gari ^a   Blum, Miriam ^a   Iaina, Adrian ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CONTRAST MEDIUM; CYCLOSPORIN A; GENTAMICIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; URANYL NITRATE;

ACUTE KIDNEY FAILURE; GLOMERULUS FILTRATION; GRANULOCYTE; HUMAN; KIDNEY CIRCULATION; KIDNEY EPITHELIUM; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY VASCULAR RESISTANCE; MYOGLOBINURIA; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SODIUM ABSORPTION;

ANIMALS; HUMANS; ISCHEMIA; KIDNEY FAILURE, ACUTE; NITRIC OXIDE;

EID: 0029947628     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189096     Document Type: Article

References (82)

1. MacAllistcr R. Vallancc P: Nitric oxide in essential and renal hypertension. J Am Soc Nephrol 1994;5:1057-1065.
2. Raij L: Nitric oxide and the kidney. Circulation 1993;87:V26-V29.
3. Forstcrmann U. Pollock JS. Nakanc M: Nitric oxide synthases in the cardiovascular system. Trends Cardiovasc Med 1993;3:104-110.
4. Shultz PJ. Archicr SL. Rosenberg ME: Inducible nitric oxide synthase rnRNA and activity in glomerular mesangial cells. Kidney Int 1994: 46:683-689.
5. Mohaupt MG. Elzie JL. Ahn KY. Clapp WE, Wilcox C. Kone BC: Differential expression and induction of rnRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 1994:46:653-665.
6. Shultz PJ, Taych MA. Marietta MA. Taij L: Synthesis and action of nitric oxide in rat glomerular ntcsangial cells. Am J Physiol 1991:30: F600-F606.
7. Tojo A, Gross SS, Zhang LC, Tisher CC. Schmidt HHHW. Wilcox CS. Madsen KM: Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney. J Am Soc Nephrol 1994:4:1438-1447.
8. Morrissey JJ. McCracken R. Kaneto H, Vehas-kari M, Montani D. Klahr S: Location of an inducible nitric oxide synthase rnRNA in the normal kidney. Kidney Int 1994:45:998-1005.
9. Natan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992:6:3051-3064.
10. Ruilope LM, Lahera V, Rodicio JL. Romero JC: Participation of nitric oxide in the regulation of renal function: Possible role in the genesis of arterial hypertension. J Hypcrtens 1994: 12:625-631.
11. Ichikawa I: Hemodynamic influence of altered distal salt delivery on glomerular microcirculation. Kidney Int 1992;22(suppl 12): 109-113.
12. Molitoris BA: Cellular basis of ischemic acute renal failure: in Lazarus JM. Brenner BM (cds): Acute Renal Failure. Edinburgh. Churchill Livingstone, 1992, pp 1-32.
13. Masters BSS: Nitric oxide synthases: Why so complex? Annu Rev Nutr 1994;14:131-145.
14. Willingcr CC. Schramek H. Pfaller K. Pfaller W: Tissue distribution of neutrophils in post-ischemic acute renal failure. Virchows Arch [B] 1992:62:237-243.
15. Paller MS: Effect of neutrophil depiction on ischemic renal injury in the rat. J Lab Clin Med 1989;113:379-386.
16. Klausncr JM. Paterson IS, Goldman G, Kobzik L, Rodzen C. Lawrence R. Valeri CR. Shepro D. Hcchtman HB: Post ischemic renal injury is mediated by neutrophils and Icukotricncs. Am J Physiol 1989:256:F794-F802.
17. Hcllberg PO, Kallskog OT. Ojtcg G, Wolgast M: Peritubular capillary permeability and in-travascular RBC' aggregation after ischemia: Effects of neutrophils. Am J Physiol 1990:258: F1018-F1025.
18. Thornton MA, Winn R. Alpers CE. Zager RA: An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am J Pathol 1989:135:509-515.
19. Linas SL. Whittenburg D, Parsons PE. Repine JE: Mild renal ischemia activates primed neutrophiles to cause acute renal failure. Kidney Int 1992:42:610-616.
20. Murohara T. Buerke M, Lefer AM: Polymorphonuclear leukocyte-induced vasoconstriction and endothelial dysfunction. Role of se-lectins. Artcriosclcr Thromb 1994; 14:1509-1519.
21. Davenpcck KL. Gauthier TW. Albertinc KH. Lefer AM: Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischcmia-rcpcrfusion. Am J Physiol 1994:267: H622-H630.
22. Lefer AM. Ma XL: PMN adherence to cat isch-cmic-repcrfuscd mesenteric vascular endothelium under How: Role of P-selectin. J Appl Physiol 1994;76:33-38.
23. Lefer AM. Wcyrich AS. Buerke M: Role of selectins: A new family of adhesion molecules in ischemia-rcpcrlusion injury. Cardiovasc Res 1994:28:289-294.
24. Buerke M. Weyrich AS. Zheng Z, Gacta FC. Forrest AM: Sialyl Lewis x-containingoligosac-charide attenuates myocardial repcrfusion injury in cats. J Clin Invest 1994:93:1140-1148.
25. Kubcs P. Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sei USA 1991:88:4651-4655.
26. Ma XL. Wcyrich AS, Lefer DJ, Lefer AM: Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. CircRes 1993:72:403-412.
27. Lefer AM, Ma XL. Weyrich A, Lefer DJ: Endothelial dysfunction and neutrophil adherence as critical events in the development of repcrfusion injurv. Agents Action 1993:41 (suppl): 127-135.
28. Lefer AM. Siegfried MR. Ma XL: Protection of ischcmia-rcpcrfusion injury by syndonimine NO donors via inhibition of neutrophil-endo-thclium interaction. J Cardiovasc Pharmacol 1993;22:S27-S33.
29. Kanwar S. Tepperman BL. Payne D. Sutherland LR. Kubcs P: Time course of nitric oxide production and epithelial dysfunction during ischcmia/rcpcrfusion of the feline small intestine. Circ Shock 1994;42:135-140.
30. Gauthier TW, Davenpcck KL. Lefer AM: Nitric oxide attenuates leukocyte-endothelial interaction via P-selcctin in splanchnic ischemia-reperfusion. Am J Physiol 1994;267:G562-G568.
31. Kubes P. Kurose I. Granger DN: NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-depcndent rolling in post-ischemic venules. Am J Physiol 1994:267: H931-H937.
32. Provost P, Lam JYT. Lacoste L. Merhi Y, Walters D: Endothclium-dcrived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Artcriosclcr Thromb 1994:14:331-335.
33. Conger JD, Robinette JB. Schrier RW: Smooth muscle and endothelium-derived relaxing factor in the abnormal vascular response of acute renal failure. J Clin Invest 1988:82:532-537.
34. Lieberthal W, Wolf EF. Rcnnkc HG, Valeri CR, Lcvinskv NG: Renal ischemia and reperfusion impair endothelium-dependent relaxation. Am J Physiol 1989;256:F894-F900.
35. Cristol JP. Thiemermann C. Mitchell JA. Wälder C, Vane JR: Support of renal blood How after ischemic-reperfusion injurs' by endogenous formation of nitric oxide and of cy-clo-oxvgcnasc vasodilator metabolites. Br J Pharmacol 1993:109:188-194.
36. Ascer E. Mohan C. Gennaro M. Cupo S: Interleukin-1 and thromboxane release after skeletal muscle ischaemia and repcrfusion. Ann Vase Surg 1992:6:69-73.
37. Hecker M. Siegle I. MacArthur H. Sessa WC. Vane JR: Role of intracellular thiols in release of EDRF from cultured endothelial cells. Am J Physiol 1992;262:H888-H896.
38. Tome LA. Campos SB, Seguro AC: Protective effect of ¿-arginine on post-ischemic acute renal failure (abstract). Kidney Int 1994:46: 1747.
39. Schering MS. Chiu PJ, Vemulapalli S. Watkins RW. Sybcrtz EJ: Inhibition of endothelial derived relaxing factor aggravates ischemic acute renal failure in anesthetized rats. Naunyn Schmeidcbcrgs Arch Pharmacol 1993:348: 305-310.
40. Espinosa G. Lopez-Farre A. Encabo B, Cema-das MR. Millan P. Monton M. Riesco A. Galle-go MJ. Hernando L. Casado S. Caramelo C: Effects of ¿-arginine on acute renal ischaemia reperfusion-induccd injury: Role of simultaneous administration of Superoxide dismutase (abstract). Nephrol Dial Transplant 1992:7: 700.
41. Yu L. Gengaro PE, Niederberger M. Burke TJ. Schrier RW: Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sei USA 1994;91:1691-1695.
42. Weyrich AS. Ma XL. Lefer AM: The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-288.
43. Siegfried MR. Erhard! J. Rider T, Ma XL. Le-fcr AM: Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischcmia-reperfusion. J Pharmacol ExpTher 1992:260:668-675.
44. Lefer DJ. Nakanishi K. Johnston WE. Vinten-Johansen J: Antincutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs. Circulation 1993;88:2337-2350.
45. Siegfried MR. Carey C. Ma XL. Lefcr AM: Beneficial effects of SPM-5185. a cystcinc-con-taining NO donor in myocardial ischcmia-repcrfusion. Am J Physiol I992:263:H771-H777.
46. Xiong L. Mazmanian M. Chapelicr AR. Reig-nier J. Weiss M. Dartevellc PG. Herve P: Lung preservation with Euro-Collins. University of Wisconsin. Wallwork. and low-potassium-dex-tran solution. Ann Thorac Surg 1994:58:845-850.
47. Larson TS. Hudson KJ. Mertz H. Romero C. Knox FG: Renal vasoconstriction response to contrast media. The role of sodium balance and renin angiotensin system. J Lab Clin Med 1983:101:630-636'
48. Humes HD. Hunt DA. White MD: Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol 1987; 252:F246-F255.
49. Hevman SN. Clark BA. Kaiser N. Spokes K. Rosen S. Brezis M. Epstein FH: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992:3:58-65.
50. Schwartz D. Blum M, Peer G. Wollman Y, Marce A. Serban I. Grosskopf I, Cabili S. Levo Y. Haina A: Role of nitric oxide (EDRF) in radiocontrast acute renal failure in rats. Am J Physiol 1994:267:F374-F379.
51. Agmon Y. Peleg H. Grccnfcld Z. Rosen S. Brezis M: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994:94:1069-1075.
52. Wollman Y. Chemihovsky T, Blum M. Peer G, Weinstein T. Silvcrbcrg DS. Kaplan E. laina A: The effect of contrast media on the rat cultured mcsangial cells nitric oxide production (abstract). ISN Satellite Symposium on Acute Renal Failure, Barcelona, July 1995.
53. Conger JD. Kim GE. Robinette JB: Effects of ANG-1I. ETA. and TxA; receptor antagonists on cyclosporin A renal vasoconstriction. Am J Physiol 1994;267:F443-F449.
54. Kon V. Sugiura M. Inagami T. Harvic BR. Ichikawa I, Hoover RL: Role of endothelin in cvclosporine-induced glomerular dysfunction. Kidney lnt 1990:37:1487-1491.
55. Gallego MJ, Garcia Villalon AL. Locpz Farre AJ. Garcia JL. Garron MP: Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide. cGMP. and Cab Circ Res 1994; 74:477-484.
56. Burkart V. Imai Y. Kallman B. Kolb H: Cyclosporin A protects pancreatic islet cells from nitric oxide dependent macrophage cxytotoxieity. FEBS Lett 1992:313:56-58.
57. Akita K, Dusting GJ. Kiskey H: Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells. Clin Exp Pharmacol Physiol 1994:21:231-233.
58. Cairns HS. Fairbanks LD. Wcstwick J. Neild GH: Cyclosporin therapy in vivo attenuates the response to vasodilators in the isolated perfused kidney of the rabbit. Br J Pharmacol 1989;98:463-468.
59. Richards NT. Poston L. Hilton PJ: Cyclosporin A inhibits endothelium-dependent, prostanoid-induced relaxation in human subcutaneous resistance vessels. J Hypertens 1990:8: 159-163.
60. Carrier M. Tronc F. Stewart D. Pelletier LC: Dose-dependent effect of cyclosporin on renal arterial resistance in dogs. Am J Physiol 1991: 26 LH1791-LH1796.
61. Muhl H. Kunz D, Rob P. Pfcilschiftcr J: Cyclosporin derivatives inhibit interleukin-1-beta induction of nitric oxide synthase in renal me-sangial cells. Eur J Pharmacol 1993:249:95-100.
62. Maree A. Peer G. Schwartz D. Serban I. Blum M, Wollman Y, Cabili S, laina A: Role of nitric oxide in glycerol-induced acute renal failure in rats. Nephrol Dial Transplant 1994;9(suppl 4): 78-81.
63. Schramm L. Heidbreder E. Lopau K. Schaar J. Dc Cico D. Gotz R, Hcidland A: Toxic acute renal failure in the rat: Effects of /,-argininc and N-mcthvl-L-arginine on renal function. Nephrol Dial Transplant 1994:9(suppl 4):88-93.
64. Rivas-Cabanero RL. Montero A. Lopez-Novoa JM: Increased glomerular nitric oxide synthase in gentamicin-induced acute renal failure. Eur J Pharmacol 1994:270:119-121.
65. Papadimitriou M. Economidou D. Vakianis P. Raidis Ch, Vrctlos M. Margari P: Effect of inhibition of nitric oxide synthase in acute renal failure due to endotoxin shock in dogs. Nephrol Dial Transplant 1994;9(suppl 4):82-87.
66. laina A. Schwartz D: Renal tubular cellular and molecular events in acute renal failure. Nephron 1994:68:413-418.
67. Ketteler M. Border WA. Noble NA: Cytokines and β-argininc in renal injury and repair. Am J Physiol I994;267:F197-F207.
68. Hammerman MR. Miller SB: Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 1994:5:1-11.
69. Miller SB, Martin DR. Kissane J. Hammerman MR: Rat models for clinical use of insulinlike growth factor I in acute renal failure. Am J Physiol 1994;266:F949-F956.
70. Noguchi S. Kashihara Y. Ikcganti Y. Morimoto K. Miyamoto M. Nakao K: Insulin-like growth factor 1 ameliorates transient ischemia-induced acute renal failure in rats. J Pharmacol Exp Ther 1993:267:919-926.
71. Burden ST. Vanhoutte PM: Regulation of smooth muscle cell growth by endothelium-derived factors. Tex Heart Inst J 1994:21:91-97.
72. Schini VB. Dutante W. Elizondo E. Burden ST. Junquero DC, Achafer A, Vanhoutte PM: The induction of nitric oxide synthase activity is inhibited by TGF-beta-1. PDGFAB, PDGFBB. in vascular smooth muscle cells. Eur J Pharmacol 1992:216:379-383.
73. Maese K. Bonicce I, DeMeo D, Wagner JA: Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J Neurosci 1993;13:3034-3040.
74. Burden ST. Schini VB. Elizondo E. Junquero DC. Vanhoutte PM: Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric ox:dc by cultured smooth muscle cells. Effects of cell proliferation. Circ Res 1992:71: 1088-1100.
75. Heck DE. Laskin DL. Gardner CR. Laskin JD: Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by kcra-tinocytcs. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 1992;267:21277-21280.
76. Kourembanas S. McQuillan LP. Leung GK, Faller DV: Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993:92:99-104.
77. Pfcilschiftcr J. Kunz D. Muhl H: Nitric oxide: An inflammatory mediator of glomerular mcsangial cells. Nephron 1993:64:518-525.
78. Junquero DC, Burden St. Schini BV, Vanhouttc PM: Inhibition of cytokine-induced nitric oxide production by transforming growth factor-pi in human smooth muscle cells. J Physiol (Lond) 1992:454:451-465.
79. Vodovolz Y. Bogdan J, Paik J, Xie QW, Nathan C: Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-p. J Exp Med 1993; 178:605-613.
80. Roberts AB. Vodovotz Y, Roche NS, Sporn MB. Nathan CF: Role of nitric oxide in antagonistic effects of transforming growth factor-p and interleukin-ip on the beating rate of cultured cardiac myocytes. Mol Endocrinol 1992: 6:1921-1930.
81. Schricr RW, Burke TJ: New aspects in pathogenesis of acute renal failure. Nephrol Dial Transplant 1994;9(suppl 4):9-14.
82. Hammerman MR. Miller SB: The growth hormone insulin-like growth factor axis in kidney revisited. Am J Physiol 1993;265:F1-F14.